Independent & educational platform Not a government body. No link or affiliation with any government organisation. Made for learning only. Test only systems you own or are authorised to test. Become a Partner or Sponsor → Full disclaimer

CVE-2025-15399

critical

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could all…

IBM Common Licensing Agent 9.0, Agent 9.0.0.1, Agent 9.0.0.2, ART 9.0, ART 9.0.0.1, and ART 9.0.0.2 is vulnerable to cross-site request forgery which could allow an attacker to execute malicious and unauthorized actions transmitted from a user that the website trusts.

CVSS
10.0
10.0 (CVSS v3.1)
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H
Severity source: NVD CVSS v3.1 (psirt@us.ibm.com)
Timeline (UTC)
Published: 2026-09-18 16:17
Modified: 2026-10-14 18:10
NVD status: Awaiting Analysis
Last synced 2 days ago
Verified against the source API 2026-10-27 06:54 UTC
Exploitation
Not listed in CISA KEV (as of last catalog sync)
Absence from KEV does not mean a CVE is not exploited. Exploitation status: unknown (no authoritative evidence in our sources).

Affected products

Not reported by the source (unknown — not "none").

Weakness classification (CWE)

Source: NVD / CISA. “NVD-CWE-Other” and “NVD-CWE-noinfo” mean NVD could not assign a specific weakness.

Mitigation & advisories

No vendor advisory or patch reference tagged by NVD. Check the references below.

References

Data sources

NVD CVE API 2.0 — fetched 2026-10-27 06:54 UTC · record ↗

Learn the basics

Understanding CVEs and CVSS Scores